Harmony Biosciences Holdings (HRMY) Net Income towards Common Stockholders Growth (1y) (2020 - 2026)
Harmony Biosciences Holdings (HRMY) Net Income towards Common Stockholders Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -58.11% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 104.24% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -129.68% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -290.15% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn | -28.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.69% |
| Dec 31, 2025 | -52.98% |
| Sep 30, 2025 | 10.35% |
| Jun 30, 2025 | 243.16% |
| Mar 31, 2025 | 18.85% |
| Dec 31, 2024 | 196.69% |
| Sep 30, 2024 | 19.84% |
| Jun 30, 2024 | -66.21% |
| Mar 31, 2024 | 30.01% |
| Dec 31, 2023 | 171.08% |
| Sep 30, 2023 | -56.27% |
| Jun 30, 2023 | 45.77% |
| Mar 31, 2023 | 37.24% |
| Dec 31, 2022 | -264.81% |
| Sep 30, 2022 | 1,014.17% |
| Jun 30, 2022 | 66.69% |
| Mar 31, 2022 | 190.89% |
| Dec 31, 2021 | 11,020.19% |
| Sep 30, 2021 | -134.41% |
| Jun 30, 2021 | 234.79% |